Article · 2014
Reviewer
Jozef Oleksyszyn
Wroclaw University of Technology, Poland
About
As published by the journal they serve.
Jozef Oleksyszyn has recived his Ph.D. (1974-1977) and D.S. (doctor of sciences, habilitation, 1978-1986) from Faculty of Chemistry, Wrocław University of Technology. Currently he is professor of biochemistry at that place. Two postdoctoral scholarship. The first (1982-1984) at Department of Chemistry, Michigen University with prof. Arthur Ashe and the second one at Georgia Institute of Technology with prof. James C. Powers. During the period of 1990-2000 has been working in few biotechnology companies including CORTECH Inc., (Denver,CO), OsteoArthritis Inc., (Boston, MA) and DYAX (Boston, MA), at positions from research scientist to the Director of Chemical Sciences. One of the compounds, inhibitor of human neutrophil elastase, designed and synthesized by him went to the clinical trial (Cortech). He discovered an amidoalkylation reaction of trivalent phosphorus derivatives, named in literature sometimes “Oleksyszyn reaction”. In prof. Powers lab he discovered a new class of selective and potent, serine protease inhibitors – diaryl 1-aminoalkylphosphonates. In 2002 he returned to Wrocław Technology University, where he build-up the Division of Medicinal Chemistry and Microbiology that he has been headed during the period 2006-2011. His research resulted in more than 70 publications in reputed journals and more than 50 patents and patents applications, including 8 USA patents. His is a member of American Chemical Society. He has been serving as editorial member of several reputed journal like Journal Anti-cancer Agents in Medicinal Chemistry, American Journal of Cancer Prevention, Journal of Pharmacological & Biomedical Analysis, Cell Biology:Research & Therapy, and expert Revivers for several Journals.
Journals they serve
The seats these journals name them in.
- Cancer Science & TherapyReviewer
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2014
Cancer Ã?¢Ã?â?¬Ã?â?? Could it be Cured? A Spontaneous Regression of Cancer, Cancer Energy Metabolism, Hyperglycemia-Hypoglycemia, Metformin, Warburg and Crabtree Effects and a New Perspective in Cancer Treatment
Article · 2013
Cancer could be cured?
Article · 2016
Development of novel inhibitors targeting NS3/4A protease of hepatitis C virus
Article · 2015
Targeting viral serine proteases with phosphonic inhibitors
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
